Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden

Journal of Epidemiology and Community Health

Volumn 62, Issue 5, 2008, Pages 398-401

  Hemminki, K ^a,b   Li, X ^b   Sundquist, K ^b   Sundquist, J ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPSIN INHIBITOR;

DISEASE INCIDENCE; ENVIRONMENTAL RISK; HEALTH RISK; HERITABILITY; HOSPITAL SECTOR; RESPIRATORY DISEASE; RISK FACTOR; SIBLING; SMOKING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; CHILD; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILY STUDY; FEMALE; GENE INTERACTION; GENETIC RISK; GROUPS BY AGE; HERITABILITY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; NEWBORN; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIBLING; SPOUSE; TWINS;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK FACTORS; SIBLINGS; SPOUSES; SWEDEN;

EURASIA; EUROPE; NORTHERN EUROPE; SCANDINAVIA; SWEDEN;

NICOTIANA TABACUM;

EID: 42549091166     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2007.063156     Document Type: Article

References (28)

1. Hogg J. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-21.
2. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-66.
3. Jyrki-Tapani K, Sovijarvi A, Lundback B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD 2005;2:331-9.
4. Montnemery P, Lanke J, Lindholm LH, et al. Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey. Eur J Epidemiol 2000;16:1003- 7.
5. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:16-22.
6. Hemminki K, Lorenzo Bermejo J, Försti A. The balance between heritable and environmental aetiology of human disease. Nature Rev Cancer 2006;7:958-65.
7. TheInternationalHapMapConsortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
8. Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J 1999;13:247-51.
9. Aldonyte R, Eriksson S, Piitulainen E, et al. Analysis of systemic biomarkers in COPD patients. COPD 2004:155-64.
10. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001;163:469-73.
11. Molfine N. Genetics of COPD. Chest 2004;125:1929-40.
12. Silverman E. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006;3:405-8.
13. McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001:164.
14. Nihlen U, Nyberg P, Montnemery P, et al. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med 2004;98:263-70.
15. Bense L, Eklund G, Lewander R. Hereditary pulmonary emphysema. Chest 2002;121:297-300.
16. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004;292:1480-9.
17. Hemminki K, Li X, Johansson S, et al. Familial risks for migraine and other headaches among siblings based on hospitalisations in Sweden. Neurogenetics 2005;6:217-24.
18. Hemminki K, Li X, Sundquist K. Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006;9:580-6.
19. Sundquist K, Li X, Hemminki K. Familial risk of ischemic and hemorrhagic stroke: a large-scale study of the Swedish population. Stroke 2006;37:1668-73.
20. Hemminki K, Vaittinen P, Dong C, et al. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001;84:388-91.
21. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
22. Hemminki K, Jiang Y. Cancer risks among long-standing spouses. Br J Cancer 2002;86:1737-40.
23. Madden PA, Pedersen NL, Kaprio J, et al. The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res 2004;7:82-97.
24. Li X, Hemminki K. Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer 2004;112:451- 7.
25. Hemminki K, Li X, Sundquist K, et al. Familial risks for asthma among twins and other siblings based on hospitalisations in Sweden. Clin Exp Allergy 2007;37:1320-5.
26. Burke W, Fesinmeyer M, Reed K, et al. Family history as a predictor of asthma risk. Am J Prev Med 2003;24:160-9.
27. Hemminki K, Li X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 2004;110:291- 4.
28. Geijer RM, Sachs AP, Verheij TJ, et al. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice? Scand J Prim Health Care 2006;24:237-42.